Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral agent that causes
Coronavirus disease 2019 (COVID-19), a disease that causes flu-like symptoms that, when …

Summary Coronavirus disease 2019 (COVID‐19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) and has resulted in more than 6 million deaths …

COVID-19 remains a global pandemic of an unprecedented magnitude with millions of
people now developing “COVID lung fibrosis.” Single-cell transcriptomics of lungs of patients …

Antiviral type I interferons (IFN) produced in the early phase of viral infections effectively
inhibit viral replication, prevent virus-mediated tissue damages and promote innate and …

COVID-19 is an acute, complex disorder that was caused by a new β-coronavirus severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on current reports, it was …

Extracellular vesicles (EVs) have emerged as potential mediators of intercellular
communication. EVs are nano-sized, lipid membrane–bound vesicles that contains …

Sex differences in the susceptibility of SARS-CoV-2 infection and severity have been
controversial, and the underlying mechanisms of COVID-19 in a sex-specific manner remain …

The clinical outcome of SARS-CoV-2 infection varies widely between individuals. Machine
learning models can support decision making in healthcare by assessing fatality risk in …

To explore how the immune system controls clearance of SARS-CoV-2, we used a single-
cell, mass cytometry–based proteomics platform to profile the immune systems of 21 patients …

In addition to an inflammatory reaction, Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2)-infected patients present lymphopenia, which we recently reported as being …